Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Passes Above Fifty Day Moving Average of $2.81

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRFGet Free Report) (TSE:CPH) shares crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.81 and traded as high as $3.34. Cipher Pharmaceuticals shares last traded at $3.30, with a volume of 8,400 shares.

Analysts Set New Price Targets

Separately, Stifel Nicolaus upgraded Cipher Pharmaceuticals from a “hold” rating to a “buy” rating in a report on Thursday, June 1st.

View Our Latest Research Report on CPHRF

Cipher Pharmaceuticals Price Performance

The company has a 50-day moving average price of $2.81 and a 200-day moving average price of $2.70.

About Cipher Pharmaceuticals

(Get Free Report)

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.

Recommended Stories

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with's FREE daily email newsletter.